ClinicalTrials.gg
Not yet recruitingNCT07736274Updated Jul 30, 2026

EFFECT OF KANGAROO MOTHER CARE ON HOSPITAL OUTCOME IN LOW BIRTH WEIGHT

An interventional study of Kangaroo Mother Care and Conventional Neonatal Care in Low Birth Weight Among Neonates, sponsored by Pakistan Navy Station Shifa Hospital. Not yet recruiting at 1 site in Pakistan. Open to participants aged 1 Hour to 6 Hours. Per ClinicalTrials.gov, last updated 2026-07-30.

Sponsored by Pakistan Navy Station Shifa Hospital · Not applicable, Interventional, and Prevention

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
100
Allocation
Randomized
Ages
1 Hour to 6 Hours
Sex
All
01

Study summary

Kangaroo Mother Care is a novel intervention known to improve survival, nutrition and prevent infections. Kangaroo Mother Care encompasses prolonged skin-to-skin contact between the mother and the baby and exclusive breastfeeding till the end of neonatal period or until the baby wriggles out, whichever is earlier.Studies have shown that kangaroo mother care has benefits for infants and mothers, including reduction in infant mortality rate, maintenance of the neonate's temperature and promoting breastfeeding. Kangaroo mother care also improves the infant's respiratory rate, oxygen saturation, weight gain, sleeping condition and physical growth. It has a positive effect on physical growth and motor development of newborns. Kangaroo mother care decreases the neonates need for phototherapy and repeated admission for neonatal jaundice in low birth weight infants. The objective of study is to compare the outcome with and without kangaroo mother care in neonates with low birth weight.

02

Conditions studied

  • Low Birth Weight Among Neonates

Browse trials for

Keywords

  • Neonates
  • Kangaroo Mother Care
  • Birth weight
03

In context

Birth Weight

185 studies on the registry are indexed under Birth Weight; 24 are open to participants now.

This study's planned enrollment of 100 is below the median of 170 across 117 interventional studies indexed under Birth Weight.

Browse Birth Weight studies →

Lead sponsor

Pakistan Navy Station Shifa Hospital is the lead sponsor of 6 studies on the registry; 1 is open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
1 Hour to 6 Hours
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

Neonates of age 1-6 hours, both genders Delivered >32 weeks of gestation (as per maternal record) Delivered either via cesarean section or vaginal delivery With low birth weight (1500-2000 grams)

Exclusion criteria

Exclusion Criteria:

  • Children with major congenital disorder, cleft lip and palate, cyanotic heart disease, congenital anomaly,

    • Having chromosomal abnormality or Down's score >7 at admission
    • Neonates of birth weight \<1500 grams, need NICU admission for surfactant or resuscitation
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
100 participants (estimated)

Study arms

  • Experimental
    Group A, neonates will be given kangaroo mother care

    Behavioral: Kangaroo Mother Care

  • Active comparator
    Group B, neonates will be given conventional neonatal care

    Other: Conventional Neonatal Care

Interventions

  • BehavioralKangaroo Mother Care

    Kangaroo Mother Care encompasses prolonged skin-to-skin contact between the mother and the baby and exclusive breastfeeding till the end of neonatal period or until the baby wriggles out, whichever is earlier

  • OtherConventional Neonatal Care

    Conventional pharmacotherapy and supportive care provided in low birth weight neonates

06

What researchers measure

Primary outcomes

  1. Mean Weight Gain

    It will be calculated in terms of g/day as difference in weight before and after 40 days of trial, divided by 40 (number of days)

    Time frame: 40 days

  2. Mean Head Circumference Gain

    It will be calculated in terms of cm/week as difference in weight before and after 40 days of trial, divided by 6 (weeks during 40 days)

    Time frame: 6 weeks

  3. Hypothermia

    It will be labeled if body temperature falls below 98.6oF at any point during follow-up of 40 days

    Time frame: 40 days

07

Study locations

1 site
  • PNS Shifa Hospital Karachi
    Karachi, Sindh 75557, Pakistan
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Sep 2026; primary completion for Nov 2026, 2 months later.

Of 43 non-industry interventional studies with no phase under Birth Weight, half reached primary completion within 20 months of starting (the median), counting those still running; a quarter within 15 and three quarters within 36. This study's planned 2 months is below that.

Counting every sponsor, half of 44 studies reached it within 19 months; a quarter within 15 and three quarters within 36.

How these figures are worked out, and which studies are left out of them.

Registered
Jul 25, 2026
First posted
Jul 30, 2026
StartEst.
Sep 1, 2026
Primary completionEst.
Nov 30, 2026
CompletionEst.
Nov 30, 2026
Last update
Jul 30, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jul 30, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07736274
Lead sponsor
Pakistan Navy Station Shifa Hospital
Responsible party
Hina Baby (Investigator, Pakistan Navy Station Shifa Hospital) — Principal investigator
First posted
Jul 30, 2026
Start date
Sep 1, 2026 (estimated)
Primary completion
Nov 30, 2026 (estimated)
Completion
Nov 30, 2026 (estimated)
Last update
Jul 30, 2026

Study contacts

Dr Hina Baby, MBBS
Contact
Shaikhhinababy@gmail.com
+923053009768

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Jul 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion